Interleukin-33 could play an important role in the pathogenesis of periodontitis

Journal of Periodontal Research

Volumn 50, Issue 4, 2015, Pages 525-534

  Koseoglu S ^a   Hatipoglu M ^b   Saglam M ^a   Enhoş, Ş ^a   Esen, H H ^c  

^a IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^b AKDENIZ UNIVERSITY   (Turkey)

^c NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

Author keywords

Alveolar bone loss; Interleukin 33; Osteoprotegerin; Periodontal disease; RANKL protein; Rat

Indexed keywords

IL33 PROTEIN, RAT; INTERLEUKIN 33; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TNFRSF11B PROTEIN, RAT;

ADVERSE EFFECTS; ALVEOLAR BONE LOSS; ANIMAL; BONE DEVELOPMENT; CELL COUNT; COMPARATIVE STUDY; INFLAMMATION; MAST CELL; OSTEOBLAST; OSTEOCLAST; PATHOLOGY; PERIODONTITIS; PHYSIOLOGY; RAT; SUTURE; WISTAR RAT;

ALVEOLAR BONE LOSS; ANIMALS; CELL COUNT; INFLAMMATION; INTERLEUKIN-33; MAST CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; PERIODONTITIS; RANK LIGAND; RATS; RATS, WISTAR; SUTURES;

EID: 84935712851     PISSN: 00223484     EISSN: 16000765     Source Type: Journal    
DOI: 10.1111/jre.12235     Document Type: Article

References (42)

1. Hughes FJ. Cytokines and cell signalling in the periodontium. Oral Dis 1995;1:259-265.
2. Barksby HE, Lea SR, Preshaw PM, Taylor JJ. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 2007;149:217-225.
3. Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007;37:2779-2786.
4. Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev 2008;223:20-38.
5. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007;179:2551-2555.
6. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007;104:18660-18665.
7. Jiang HR, Milovanovic M, Allan D et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages. Eur J Immunol 2012;42:1804-1814.
8. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007;117:1538-1549.
9. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-490.
10. Lunderius-Andersson C, Enoksson M, Nilsson G. Mast cells respond to cell injury through the recognition of IL-33. Front Immunol 2012;3:82.
11. Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol 2011;38(suppl 11):60-84.
12. Divaris K, Monda KL, North KE et al. Genome-wide association study of periodontal pathogen colonization. J Dent Res 2012;91:21S-28S.
13. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature 2003;423:337-342.
14. Bostanci N, Ilgenli T, Emingil G et al. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases. J Periodontal Res 2007;42:287-293.
15. Bostanci N, Ilgenli T, Emingil G et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol 2007;34:370-376.
16. Schulze J, Bickert T, Beil FT et al. Interleukin-33 is expressed in differentiated osteoblasts and blocks osteoclast formation from bone marrow precursor cells. J Bone Miner Res 2011;26:704-717.
17. Saleh H, Eeles D, Hodge JM et al. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology 2011;152:1911-1922.
18. Keller J, Catala-Lehnen P, Wintges K et al. Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis. Biochem Biophys Res Commun 2012;417:217-222.
19. Toker H, Ozdemir H, Eren K, Ozer H, Sahin G. N-acetylcysteine, a thiol antioxidant, decreases alveolar bone loss in experimental periodontitis in rats. J Periodontol 2009;80:672-678.
20. Demirer S, Kara MI, Erciyas K, Ozdemir H, Ozer H, Ay S. Effects of boric acid on experimental periodontitis and alveolar bone loss in rats. Arch Oral Biol 2012;57:60-65.
21. Huang S, Lu F, Chen Y, Huang B, Liu M. Mast cell degranulation in human periodontitis. J Periodontol 2013;84:248-255.
22. Yu H, de Vos P, Ren Y. Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. Angle Orthod 2011;81:100-106.
23. Christopher MJ, Link DC. Granulocyte colony-stimulating factor induces osteoblast apoptosis and inhibits osteoblast differentiation. J Bone Miner Res 2008;23:1765-1774.
24. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008;79:1569-1576.
25. Koo HM, Do HM, Kim EJ et al. Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. Atherosclerosis 2011;219:925-930.
26. Sakata M, Shiba H, Komatsuzawa H et al. Osteoprotegerin levels increased by interleukin-1beta in human periodontal ligament cells are suppressed through prostaglandin E(2) synthesized de novo. Cytokine 2002;18:133-139.
27. Mun SH, Ko NY, Kim HS et al. Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes. Cell Mol Life Sci 2010;67:3883-3892.
28. Hong YS, Moon SJ, Joo YB et al. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011;26:1132-1139.
29. Kageyama Y, Torikai E, Tsujimura K, Kobayashi M. Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33. Mod Rheumatol 2012;22:89-93.
30. Palmer G, Talabot-Ayer D, Lamacchia C et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009;60:738-749.
31. Xiangyang Z, Lutian Y, Lin Z, Liping X, Hui S, Jing L. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 2012;58:6-9.
32. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C. Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 2011;186:2523-2528.
33. Verri WA Jr, Souto FO, Vieira SM et al. IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 2010;69:1697-1703.
34. Xu D, Chan WL, Leung BP et al. Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med 1998;188:1485-1492.
35. Seidelin JB, Rogler G, Nielsen OH. A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol 2011;4:496-502.
36. Gemmell E, Seymour GJ. Cytokine profiles of cells extracted from humans with periodontal diseases. J Dent Res 1998;77:16-26.
37. Vernal R, Dutzan N, Hernandez M et al. High expression levels of receptor activator of nuclear factor-kappa B ligand associated with human chronic periodontitis are mainly secreted by CD4+ T lymphocytes. J Periodontol 2006;77:1772-1780.
38. Moussion C, Ortega N, Girard JP. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 2008;3:e3331.
39. Carriere V, Roussel L, Ortega N et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007;104:282-287.
40. Ali S, Mohs A, Thomas M et al. The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription. J Immunol 2011;187:1609-1616.
41. Beklen A, Tsaous Memet G. Interleukin-1 superfamily member, interleukin-33, in periodontal diseases. Biotech Histochem 2013;89:209-214.
42. Buduneli N, Ozcaka O, Nalbantsoy A. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis. J Periodontol 2012;83:362-368.